Ophthalmic Cancer Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2017 - 2025
- Transparency Market Research
- Healthcare IT
Ophthalmic cancer, commonly referred as eye cancer, is a malignancy that grows in the eye. Malignant cells are cancerous cells that grow uncontrollably at a rapid pace. They also spread to others tissues of the body. Ocular melanoma is type of cancer that develops in cells which produces pigment that give color to the eyes. Ocular melanoma develops in uvea called choroid which is a pigment layer lining the eyeball. Most melanomas develop in the choroid; however, they can also develop in the iris (colored area around pupil). Melanomas in iris grow slowly and do not spread to other parts of the body. Primary intraocular lymphoma, is a type of cancer which involves lymphocytes. This is a rare type of cancer, which usually occurs in individuals with weak immune systems. The third type of cancer is retinoblastoma, which is a caused due to genetic mutation in retina, a light sensitive tissue, where retinal nerve cells begin to grow and multiply and then further spread to other parts of eyes.
The ophthalmic cancer treatment market is driven by increasing prevalence of eye cancer. Rise in the number of eye cancer cases is due to factors such as increase exposure to UV radiation from laptops, mobile phones, and greenhouse effect. Immunological disorders weaken immune system. People with weak immune systems are at a higher risk of developing eye cancer. Furthermore, government initiatives to improve health care facilities by providing treatment at minimal cost has boosted the ophthalmic cancer treatment market. However, lack of awareness regarding the early symptoms of eye cancer lead to delayed detection & onset of treatment and also cost incurred for the treatment for the underprivileged and underdeveloped parts of the world restrain the ophthalmic cancer treatment market.
The global ophthalmic cancer treatment market has been segmented based on route of administration, class of drug, end-user, and geography. In terms of route of administration, the global ophthalmic cancer treatment market has been divided into topical administration, intraocular administration, intrathecal administration, and systemic administration. Based on class of drugs, the market has been segregated into anti-metabolites, alkylating agents, antineoplastics, and monoclonal antibodies. In terms of end-user, the global ophthalmic cancer drugs market has been categorized into hospitals, ambulatory surgical centers, and cancer research institutes.
Based on regions, the global ophthalmic cancer treatment market has classified into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The ophthalmic cancer affects equally to men and women globally. In the U.S., melanoma is the most common type of cancer, followed by lymphoma. In Europe as well, incidence of ocular myeloma is high. Caucasians are more susceptible to melanoma than Africans. In the U.S. as well as Europe, ocular melanoma affects people above the age of 55 years. Therefore, the ophthalmic cancer treatment market is expected to expand in the U.S. and Europe. Choroidal melanoma is most common in adults in Asia Pacific. It affects equally to all with increasing age, mostly above 60 years of age, irrespective of gender. Even in Asia Pacific, the incidence is higher in the fairly pigmented group
The major players operating in the ophthalmic cancer treatment market are Merck & Co. Inc., F. Hoffmann La-Roche Ltd., Novartis AG., Johnson & Johnson, GlaxoSmithKline, Genetech Inc. and others.
The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.
The study is a source of reliable data on:
- Market segments and sub-segments
- Market trends and dynamics
- Supply and demand
- Market size
- Current trends/opportunities/challenges
- Competitive landscape
- Technological breakthroughs
- Value chain and stakeholder analysis
The regional analysis covers:
- North America (U.S. and Canada)
- Latin America (Mexico, Brazil, Peru, Chile, and others)
- Western Europe (Germany, U.K., France, Spain, Italy, Nordic countries, Belgium, Netherlands, and Luxembourg)
- Eastern Europe (Poland and Russia)
- Asia Pacific (China, India, Japan, ASEAN, Australia, and New Zealand)
- Middle East and Africa (GCC, Southern Africa, and North Africa)
The report has been compiled through extensive primary research (through interviews, surveys, and observations of seasoned analysts) and secondary research (which entails reputable paid sources, trade journals, and industry body databases). The report also features a complete qualitative and quantitative assessment by analyzing data gathered from industry analysts and market participants across key points in the industry’s value chain.
A separate analysis of prevailing trends in the parent market, macro- and micro-economic indicators, and regulations and mandates is included under the purview of the study. By doing so, the report projects the attractiveness of each major segment over the forecast period.
Highlights of the report:
- A complete backdrop analysis, which includes an assessment of the parent market
- Important changes in market dynamics
- Market segmentation up to the second or third level
- Historical, current, and projected size of the market from the standpoint of both value and volume
- Reporting and evaluation of recent industry developments
- Market shares and strategies of key players
- Emerging niche segments and regional markets
- An objective assessment of the trajectory of the market
- Recommendations to companies for strengthening their foothold in the market
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.
Have query on this report?Make an Enquiry
The team was the biggest help to us. Not only were we provided with customized solutions but also we were guided through the most complicated situations. The information was on-point yet comprehensive. The experience was absolutely satisfying and helped us turn many challenges into opportunities.
Ours is a startup with a unique set of challenges and we were therefore hesitant but the team totally put us at ease with their knowledge and expertise. Our business and its challenges were understood perfectly and help was extended accordingly. The tailor made approach really helped us gain the most informative insights.
The report repository is absolutely impressive –updated and exhaustive in terms of markets covered and information provides. Besides, with the support extended to us by the team, we could reduce costs as well as move to sustainable growth. This really helped us tap into new opportunities. Happy to have gone ahead with ResearchMos.us.
We have had a long term engagement with ResearchMoz.us and never have we felt that the work done and help extended were below flawless. The report repository is one of the best one can hope to tap into. Recently, our partner businesses opted for consultancy services and they are all thrilled with the outcome.
Insights from reports helped us improve our profit margins significantly. Most of the knowledge we needed on the market were provided to us on a granular basis. From trends, and drivers to competitive analysis, the information was not just crisp but also insightful. That helped us chart a robust growth strategy and as of now we are happy to state that we are reaping big benefits.
More from Healthcare IT
Healthcare ITGlobal mHealth Market Research Report 2016
Pharmaceuticals and HealthcareGlobal Bionic Ears Market Professional Survey Report 2017
Pharmaceuticals and HealthcareNeuropsychiatric Disorder Cluster Drug Development Pipeline Review, 2017
Pharmaceuticals and HealthcareHepatitis Drug Development Pipeline Review, 2017